 |
 |
|
| Welcome to Ventrus Biosciences | |
|
Headquartered in New York, New York,
Ventrus Biosciences® is a publicly held specialty pharmaceutical
company focused on the late-stage clinical development of gastrointestinal products in areas of unmet
need, specifically hemorrhoids, anal fissures, and fecal
incontinence
VENTRUS BIOSCIENCES ANNOUNCES POSITIVE RESULTS FROM PIVOTAL PHASE 3 TRIAL OF DILTIAZEM (VEN 307) IN PATIENTS WITH ANAL FISSURES |
Ventrus Biosciences, Inc.
99 Hudson Street, 5th Floor, New York, NY 10013 Tel. 646-706-5208 | Fax 646-706-5101 | DBarrett@ventrusbio.com © Ventrus Biosciences, Inc. All rights reserved. Terms and conditions |